JP2002512685A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002512685A5 JP2002512685A5 JP1998534532A JP53453298A JP2002512685A5 JP 2002512685 A5 JP2002512685 A5 JP 2002512685A5 JP 1998534532 A JP1998534532 A JP 1998534532A JP 53453298 A JP53453298 A JP 53453298A JP 2002512685 A5 JP2002512685 A5 JP 2002512685A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78485597A | 1997-01-15 | 1997-01-15 | |
| US08/784,857 US5830918A (en) | 1997-01-15 | 1997-01-15 | Nonpeptide insulin receptor agonists |
| US08/784,854 US5851988A (en) | 1997-01-15 | 1997-01-15 | Nonpeptide insulin receptor agonists |
| US82526997A | 1997-03-27 | 1997-03-27 | |
| US08/784,857 | 1997-08-21 | ||
| US08/916,088 | 1997-08-21 | ||
| US08/784,854 | 1997-08-21 | ||
| US08/825,269 | 1997-08-21 | ||
| US08/916,088 US6329431B1 (en) | 1997-01-15 | 1997-08-21 | Nonpeptide insulin receptor agonists |
| US08/784,855 | 1997-08-21 | ||
| PCT/US1998/000801 WO1998032017A2 (en) | 1997-01-15 | 1998-01-15 | Modulators of insulin receptor activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002512685A JP2002512685A (ja) | 2002-04-23 |
| JP2002512685A5 true JP2002512685A5 (https=) | 2005-09-08 |
Family
ID=27542207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53453298A Ceased JP2002512685A (ja) | 1997-01-15 | 1998-01-15 | インスリン受容体活性のモジュレーター |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0960335B1 (https=) |
| JP (1) | JP2002512685A (https=) |
| AT (1) | ATE296446T1 (https=) |
| AU (1) | AU6026698A (https=) |
| CA (1) | CA2278023A1 (https=) |
| DE (1) | DE69830301T2 (https=) |
| DK (1) | DK0960335T3 (https=) |
| ES (1) | ES2242995T3 (https=) |
| WO (1) | WO1998032017A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875741B2 (en) * | 1998-09-02 | 2005-04-05 | Renuka Pillutla | Insulin and IGF-1 receptor agonists and antagonists |
| CA2343934A1 (en) | 1998-09-25 | 2000-04-06 | The Children's Medical Center Corporation | Short peptides which selectively modulate the activity of protein kinases |
| TWI234557B (en) * | 1999-05-26 | 2005-06-21 | Telik Inc | Novel naphthalene ureas as glucose uptake enhancers |
| WO2000073793A2 (en) * | 1999-05-27 | 2000-12-07 | Cecil Yip | Identification of compounds modulating insulin receptor activity |
| FR2796942B1 (fr) * | 1999-07-29 | 2003-02-07 | Telik Inc | Acides naphtylsulfoniques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2797767B1 (fr) * | 1999-08-27 | 2002-06-14 | Centre Nat Rech Scient | Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances |
| WO2001072771A2 (en) * | 2000-03-29 | 2001-10-04 | Dgi Biotechnologies, L.L.C. | Insulin and igf-1 receptor agonists and antagonists |
| AU2002245258A1 (en) * | 2001-01-12 | 2002-07-24 | Exelixis, Inc. | Modulating insulin receptor signaling |
| WO2003103648A1 (ja) * | 2002-06-05 | 2003-12-18 | 株式会社医薬分子設計研究所 | 糖尿病治療薬 |
| EP1512396A4 (en) * | 2002-06-05 | 2008-12-31 | Inst Med Molecular Design Inc | HEMMER AGAINST ACTIVATION OF AP-1 AND NFAT |
| JP4743382B2 (ja) * | 2002-06-06 | 2011-08-10 | 株式会社医薬分子設計研究所 | Ｏ−置換ヒドロキシアリール誘導体 |
| CA2488367A1 (en) * | 2002-06-06 | 2003-12-18 | Institute Of Medicinal Molecular Design, Inc. | Antiallergic agents |
| EP1535609A4 (en) * | 2002-06-10 | 2009-01-07 | Inst Med Molecular Design Inc | Nf-kb activation inhibitors |
| EA010835B1 (ru) * | 2002-06-10 | 2008-12-30 | Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. | Лекарственное средство для лечения рака |
| DE10323081A1 (de) * | 2003-05-22 | 2004-12-16 | Aventis Pharma Deutschland Gmbh | Verwendung eines Polypeptides |
| AU2006264567A1 (en) * | 2005-05-05 | 2007-01-11 | Valorisation Hsj, Societe En Commandite | Cytokine receptor modulators and uses thereof |
| US7671058B2 (en) | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995023231A1 (en) * | 1994-02-28 | 1995-08-31 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Cell lines for the identification of substances affecting insulin receptor mediated signal transduction |
| CA2216806A1 (en) * | 1995-03-31 | 1996-10-03 | Merck & Co., Inc. | Insulin mimetic and enhancer assay |
-
1998
- 1998-01-15 EP EP98903515A patent/EP0960335B1/en not_active Expired - Lifetime
- 1998-01-15 AT AT98903515T patent/ATE296446T1/de not_active IP Right Cessation
- 1998-01-15 WO PCT/US1998/000801 patent/WO1998032017A2/en not_active Ceased
- 1998-01-15 DE DE69830301T patent/DE69830301T2/de not_active Expired - Fee Related
- 1998-01-15 ES ES98903515T patent/ES2242995T3/es not_active Expired - Lifetime
- 1998-01-15 AU AU60266/98A patent/AU6026698A/en not_active Abandoned
- 1998-01-15 JP JP53453298A patent/JP2002512685A/ja not_active Ceased
- 1998-01-15 DK DK98903515T patent/DK0960335T3/da active
- 1998-01-15 CA CA002278023A patent/CA2278023A1/en not_active Abandoned